Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9268351 | Journal of Clinical Virology | 2005 | 4 Pages |
Abstract
Co-infection with GB virus C (GBV-C) and human immunodeficiency virus (HIV) appears to reduce mortality for HIV/AIDS. Epidemiological and demographic factors for GBV-C were examined prospectively in 167 subjects at risk for co-infection. We attempted to establish a hierarchical exposure risk for GBV-C. Overall exposure to GBV-C was 45.5%. In univariate analysis, GBV-C was associated with male to male sex (PÂ <Â 0.0001), HIV infection (PÂ =Â 0.0005) and hepatitis B infection (PÂ =Â 0.006). Injecting drug use approached statistical significance (PÂ =Â 0.08) while being a female sex worker was not associated with GBV-C exposure/infection (PÂ =Â 0.85). Exposure to GBV-C in 192 healthy blood donors was found to be 9.4%. In conclusion, the data suggest that male to male sex is a more effective mode of transmission of GBV-C and that GBV-C is associated with HIV co-infection. As male to male sex is also a risk factor for HIV transmission our data suggest that many may benefit from the potential protective effect GBV-C exerts on HIV-infected persons.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Mark D. Berzsenyi, D. Scott Bowden, Michael J. Bailey, Cheryl White, Patrick Coghlan, Francis J. Dudley, Stuart K. Roberts,